Executive Team
Nick Medendorp, PhD
President – UnifiMI Industrial Companies
Dr. Medendorp leads the Industrial organization with a focus on commercializing innovative platform technologies. Prior to joining UnifiMI Industrial in 2024, Dr. Medendorp served in Chief Executive Officer, President and Executive Vice President roles in medical device and industrial technology companies. He holds over 130 US patents and has been a part of 5 successful exits with companies where he held leadership roles. Dr. Medendorp received his B.S., M.S. and Ph.D. in Materials Engineering from Purdue University.
Nephi Zufelt
Chief Innovation Officer
Nephi is the Chief Innovation Officer of UnifiMI Industrial Companies and has worked with the UnifiMI technology for over 10 years. Most recently Nephi was the Chief Executive Officer at NexTek Innovations, but his past work experiences have taken him all over the world, working with innovators, manufacturers, and regulatory bodies in over 35 countries. Nephi has launched over 100 products with sales of over $100M. He holds multiple patents and has authored several peer reviewed publications.
Andrew Fauth
Chief Technology Officer
Andrew is responsible for research and development, product management, quality and regulatory at OsteoCentric Technologies and UnifiMI Industrial Companies. Andrew brings to OsteoCentric over 20 years of medical device expertise. As Group General Manager, Andrew led all of the R&D activities for CoorsTek Medical (formerly MedicineLodge and IMDS) which included product development, intellectual property management, prototyping, business development, surgeon partnerships, and strategic transactions. During his tenure at CoorsTek Medical and its predecessors, Andrew was involved in hundreds of innovative orthopedic development projects spanning fields such as spine, sports medicine, extremities, trauma, joint reconstruction, general surgery, and other fields. In addition, Andrew has experience managing full-scale operations in contract manufacturing, emphasizing lean and continuous improvement processes and strategies. Andrew has Bachelor’s degree from Linfield College and both Master’s and Doctoral degrees from The Pennsylvania State University in Kinesiology/Biomechanics with a doctoral minor in Mechanical Engineering and holds over 30 issued patents.
Brian Mangum
Senior Director, Intellectual Property
Brian is responsible for strategically growing the OsteoCentric patent portfolio in the medical and industrial spaces by capturing the many innovations generated by the OCT team and turning them into valuable IP assets that protect the company’s product lines and generate licensing revenue. Brian also supports marketing and branding efforts by maintaining and enforcing the company’s trademarks, and assists with negotiating and drafting licensing and other corporate agreements, among other duties.
Brian has over twenty years of varied experience as an intellectual property and corporate attorney, including stints with several law firms and public technology corporations, and a period of running his own solo practice assisting technology companies with business and intellectual property strategy, corporate formation and structuring, fundraising, and a wide variety of agreements and partnerships. He has a Bachelor of Science in Computer Engineering from Texas A&M University, and a Juris Doctor from The University of Texas at Austin School of Law. Brian is licensed to practice law in the states of Texas and California, and is a registered patent attorney with the United States Patent and Trademark Office.
RJ Brideau​
Chief Operating Officer
As COO, RJ is responsible for all operations at OsteoCentric Technologies and UnifiMI Industrial Companies. RJ brings over 20 years of management and executive leadership experience to the company. Before joining OsteoCentric and UnifiMI Industrial Companies, RJ led sales and marketing for a real-time notification and messaging solution used by physicians and hospitals to improve patient care. In prior roles, RJ has built and led partner ecosystems across manufacturing, licensing and sales for companies such as SolarWinds (IPO, NYSE: SWI), Motive (IPO, acquired by Alcatel-Lucent) and IBM. RJ graduated with honors from The Wharton School of Business with degrees in Finance and Operations, and has both Master’s and Bachelor’s degrees in Industrial Engineering and Operations Research from The Pennsylvania State University.
Jim Ford
Chief Financial Officer
As CFO, Jim is responsible for financial operations, human resources and compliance at OsteoCentric Technologies and UnifiMI Industrial Companies. Jim has a long history of management and executive levels of leadership having served in various industry sectors including banking, technology and life sciences. Most recent prior roles involved senior leadership positions of ventured back companies from startup through acquisition including LearnPlatform, Inc., Covelight Technologies (sold to Radware Ltd.), Motricity (NASD:MQTR), OpenSite (sold to Siebel Systems, Oracle), and Ventana Communications Group (sold to Thomson International). Prior to Ventana he served as the Corporate Controller for Ericsson where he led the financial operations for U.S. research and development for cellular communications. Jim is a Masters graduate of the College of Business at Florida State University and holds a B.S. in accounting and finance from Gardner Webb University. He served in the Armed Forces with the 82nd Airborne Division and was awarded the Army Commendation Medal.